Reaction Details |
| Report a problem with these data |
Target | Beta-3 adrenergic receptor |
---|
Ligand | BDBM25771 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_562923 (CHEMBL1019683) |
---|
EC50 | 1259±n/a nM |
---|
Citation | Procopiou, PA; Barrett, VJ; Bevan, NJ; Biggadike, K; Butchers, PR; Coe, DM; Conroy, R; Edney, DD; Field, RN; Ford, AJ; Guntrip, SB; Looker, BE; McLay, IM; Monteith, MJ; Morrison, VS; Mutch, PJ; Richards, SA; Sasse, R; Smith, CE Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating arylsulfonamide groups. J Med Chem52:2280-8 (2009) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-3 adrenergic receptor |
---|
Name: | Beta-3 adrenergic receptor |
Synonyms: | ADRB3 | ADRB3R | ADRB3_HUMAN | B3AR | Beta-2 adrenergic receptor and beta-3 adrenergic receptor | Beta-3 adrenoceptor | Beta-3 adrenoreceptor | adrenergic Beta3 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 43534.88 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 408 |
Sequence: | MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIV
AIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLC
VTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRV
GADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRG
ELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGT
FTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLL
CRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS
|
|
|
BDBM25771 |
---|
n/a |
---|
Name | BDBM25771 |
Synonyms: | 1-hydroxy-2-naphthoic acid;4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]-2-methylol-phenol | 4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-2-(hydroxymethyl)phenol | Aeromax | Salmeterol | Serevent | salmeterol xinafoate |
Type | Small organic molecule |
Emp. Form. | C25H37NO4 |
Mol. Mass. | 415.5656 |
SMILES | OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1 |
Structure |
|